Verastem VSTM
NASDAQ VSTM
$7.92 +0.15 (+1.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Verastem (VSTM) Notes Payables (2022 - 2026)

Updated

Verastem's Notes Payables came in at $214,000 for Q2 2026, down 54.2% from $467,000 a year earlier and down 59.5% from the prior quarter.

Analysis

Verastem (VSTM) Notes Payables (2022 - 2026) Analysis & Trends

At the end of FY2022, Verastem's Notes Payables was $275,000.

  • The five-year range for quarterly Notes Payables is $133,000 (Q3 2024) to $1 million (Q1 2023).
  • Year-over-year, Notes Payables increased in 1 of the last six quarters, with an average decline of 13.4%.
  • The fastest year-over-year change in Notes Payables over five years came in Q3 2025 (growth of 41.4%), and the weakest in Q2 2026 (a decline of 54.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Verastem 703.05 Mn 59.67 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214,000.00
Mar 31, 2026 529,000.00
Sep 30, 2025 188,000.00
Jun 30, 2025 467,000.00
Mar 31, 2025 740,000.00
Sep 30, 2024 133,000.00
Jun 30, 2024 526,000.00
Mar 31, 2024 911,000.00
Sep 30, 2023 146,000.00
Jun 30, 2023 579,000.00
Mar 31, 2023 1.00 Mn
Dec 31, 2022 275,000.00
API Access

Verastem Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=VSTM&period=max&api_key=YOUR_API_KEY